
Leo Pharma hits the speeder as the company now plans to shower the market with new treatments for both rare and more common skin diseases.
This is at the core of the pharmaceutical company’s recently announced strategy, which will function as a guideline for the company up until 2030 and position the company for launching new pharmaceutical drugs every second year, if everything goes according to plan.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app